54 related articles for article (PubMed ID: 3190363)
1. [10 years' experience in the use of vasodilator agents in the treatment of primary pulmonary arterial hypertension (P-PAH) (1977-1987)].
Beltrán Gámez ME; Sandoval Zarate J; Seoane M; Lupi-Herrera E
Arch Inst Cardiol Mex; 1988; 58(4):281-91. PubMed ID: 3190363
[TBL] [Abstract][Full Text] [Related]
2. [Clinical-hemodynamic correlation of the NYHA/WHO system in idiopathic pulmonary artery hypertension. Clinical, therapeutic and long-term prognosis implications].
Herrera EL; Zárate JS; Solano JF; Martínez LE; Zamudio TR; Bautista EG
Arch Cardiol Mex; 2008; 78(2):148-61. PubMed ID: 18754406
[TBL] [Abstract][Full Text] [Related]
3. [Evaluation of the effects of vasodilator therapy in primary pulmonary hypertension. Experience in 7 cases].
Lanzarini L; Gavazzi A; Mussini A; Graziano G; Campana C; Bargiggia G; Angoli L; Aimè E; Arbustini E; Montemartini C
G Ital Cardiol; 1990 Feb; 20(2):114-22. PubMed ID: 2328864
[TBL] [Abstract][Full Text] [Related]
4. [Effects of long-term treatment with prostacyclin on plasma adrenomedullin in patients with primary pulmonary hypertension].
Nakayama T; Ishikita T; Matsuura H; Saji T
J Cardiol; 2001 Nov; 38(5):263-71. PubMed ID: 11729726
[TBL] [Abstract][Full Text] [Related]
5. [Clinical course and prognosis in SLE patients with pulmonary hypertension: a comparative study with primary pulmonary hypertension].
Fusegawa S; Mikami T; Hashimoto M; Yamada Y; Kobayashi T; Yasuda H; Sagawa A; Fujisaku A
Kokyu To Junkan; 1991 Aug; 39(8):819-23. PubMed ID: 1925104
[TBL] [Abstract][Full Text] [Related]
6. Acute hemodynamic response to vasodilators in primary pulmonary hypertension.
Kulkarni H; Srinivas A; Vora A; Kerkar P; Dalvi B
J Postgrad Med; 1996; 42(1):7-11. PubMed ID: 9715289
[TBL] [Abstract][Full Text] [Related]
7. Experience with long-term nifedipine therapy in paediatric cardiological patients.
Wimmer M; Salzer U; Schlemmer M; Marx M; Proll E
Padiatr Padol; 1990; 25(3):181-93. PubMed ID: 2116616
[TBL] [Abstract][Full Text] [Related]
8. Role of oral sildenafil in severe pulmonary arterial hypertension: clinical efficacy and dose response relationship.
Garg N; Sharma MK; Sinha N
Int J Cardiol; 2007 Sep; 120(3):306-13. PubMed ID: 17174417
[TBL] [Abstract][Full Text] [Related]
9. [Clinical interpretation for the pressure-flow relationships in extrinsic allergic alveolitis and in interstitial lung disease pulmonary hypertension patients. Should we care for the lung, the pulmonary artery pressure or both?].
Lupi-Herrera E; Santos-Martínez LE; Pulido T; Sandoval J
Arch Cardiol Mex; 2009; 79(2):91-103. PubMed ID: 19722378
[TBL] [Abstract][Full Text] [Related]
10. [Primary pulmonary hypertension: a retrospective study of 13 patients].
Mangieri E; Ferraironi A; Avella A; Berni A; Granatelli A; Voci P; Nigri A; Reale A
Cardiologia; 1990 Dec; 35(12):1009-13. PubMed ID: 2095972
[TBL] [Abstract][Full Text] [Related]
11. Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension.
Sitbon O; Humbert M; Jaïs X; Ioos V; Hamid AM; Provencher S; Garcia G; Parent F; Hervé P; Simonneau G
Circulation; 2005 Jun; 111(23):3105-11. PubMed ID: 15939821
[TBL] [Abstract][Full Text] [Related]
12. Long-term treatment with oral sildenafil is safe and improves functional capacity and hemodynamics in patients with pulmonary arterial hypertension.
Michelakis ED; Tymchak W; Noga M; Webster L; Wu XC; Lien D; Wang SH; Modry D; Archer SL
Circulation; 2003 Oct; 108(17):2066-9. PubMed ID: 14568893
[TBL] [Abstract][Full Text] [Related]
13. Immunosuppressive therapy in lupus- and mixed connective tissue disease-associated pulmonary arterial hypertension: a retrospective analysis of twenty-three cases.
Jais X; Launay D; Yaici A; Le Pavec J; Tchérakian C; Sitbon O; Simonneau G; Humbert M
Arthritis Rheum; 2008 Feb; 58(2):521-31. PubMed ID: 18240255
[TBL] [Abstract][Full Text] [Related]
14. [Prognosis of primary pulmonary hypertension and its determinants].
Okubo S; Naito M; Nakanishi N; Obayashi Y; Kunieda T; Yutani C; Yoshioka T
J Cardiol; 1988 Dec; 18(4):1097-107. PubMed ID: 3267718
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of sildenafil as a rescue therapy for patients with severe pulmonary arterial hypertension and given long-term treatment with prostanoids: 2-year experience.
Ruiz MJ; Escribano P; Delgado JF; Jiménez C; Tello R; Gómez MA; de la Calzada CS
J Heart Lung Transplant; 2006 Nov; 25(11):1353-7. PubMed ID: 17097500
[TBL] [Abstract][Full Text] [Related]
16. Continuous intravenous epoprostenol in pulmonary hypertension: the Israel experience.
Bendayan D; Fink G; Aravot D; Ygla M; Bendov I; Bliden L; Nir A; Kramer MR
Isr Med Assoc J; 2002 Apr; 4(4):255-8. PubMed ID: 12001697
[TBL] [Abstract][Full Text] [Related]
17. Long-term outcome after pulmonary endarterectomy.
Corsico AG; D'Armini AM; Cerveri I; Klersy C; Ansaldo E; Niniano R; Gatto E; Monterosso C; Morsolini M; Nicolardi S; Tramontin C; Pozzi E; Viganò M
Am J Respir Crit Care Med; 2008 Aug; 178(4):419-24. PubMed ID: 18556630
[TBL] [Abstract][Full Text] [Related]
18. Graded balloon atrial septostomy in severe pulmonary hypertension.
Kothari SS; Yusuf A; Juneja R; Yadav R; Naik N
Indian Heart J; 2002; 54(2):164-9. PubMed ID: 12086379
[TBL] [Abstract][Full Text] [Related]
19. Ebstein's anomaly. Clinical profile in 174 patients.
Attie F; Casanova JM; Zabal C; Buendía A; Miranda I; Rijlaarsdam M; Iturralde P; Kuri J; Calderón J
Arch Inst Cardiol Mex; 1999; 69(1):17-25. PubMed ID: 10367089
[TBL] [Abstract][Full Text] [Related]
20. [Short- and long-term effects of the new oral prostacyclin analogue, beraprost sodium, in patients with severe pulmonary hypertension].
Saji T; Ozawa Y; Nakayama T; Matsuura H; Hashiguchi R; Matsuo N; Muto H; Yamazaki J; Morishita T; Saito T
J Cardiol; 1996 Apr; 27(4):197-205. PubMed ID: 8642506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
